Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
about
Effects of Oxidative Stress on Mesenchymal Stem Cell BiologyEmerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disordersSirtuin 3 deficiency does not alter host defenses against bacterial and fungal infections.Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.SIRT3 Enhances Mesenchymal Stem Cell Longevity and Differentiation.Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential.Nutrient Sensing and the Oxidative Stress Response.Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.Manganese superoxide dismutase (SOD2): is there a center in the universe of mitochondrial redox signaling?SIRT3: Oncogene and Tumor Suppressor in Cancer.A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress.The Glycolytic Switch in Tumors: How Many Players Are Involved?SIRT3-Mediated Dimerization of IDH2 Directs Cancer Cell Metabolism and Tumor Growth.Insights into the Dichotomous Regulation of SOD2 in Cancer.Redox Paradox: A novel approach to therapeutics-resistant cancer.Sirt3 enhances glioma cell viability by stabilizing Ku70–BAX interaction
P2860
Q26740408-A4F1F45B-D004-443E-B07F-FC62CEB475CAQ26741300-5C0AF9B4-BFFE-447C-9070-7947119E834DQ33818987-B19CD66A-B5C9-4282-860D-4D4F604C9AD9Q37723274-D7FF27D0-53E7-47E5-BD53-EF4F4D125AADQ38674686-CEDD1F47-FBA4-4C61-BF82-819858B4D5DFQ38838565-FF71B746-B0B2-44DA-AE49-B5B15490C006Q39185267-1090181F-DDBB-4CBC-BF6F-E26566E9677BQ39319331-7CF9785D-50D8-43C7-BAD9-D30456869C12Q39375071-116F1EB0-E640-4004-BDA1-97E9BF28208DQ39433144-0DC09352-52CC-457C-9B40-5B392BAB3E66Q41362934-8ABC53F5-0DAD-462F-B548-6E7D33EFCC68Q45419184-B2997786-1BEF-4F53-9066-329C5EBC9FFFQ46361797-B85B92FD-0263-4F59-9F93-F9C978F2BE8FQ47144151-E822FDD2-99F2-47DD-B2B5-BD819656DE2DQ50082485-34D022ED-A039-4E6E-919B-DA90E189CCA4Q59135273-02A72133-39BF-48AB-8CA2-5B3C5C5406ED
P2860
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
@ast
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
@en
type
label
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
@ast
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
@en
prefLabel
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
@ast
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
@en
P2093
P2860
P356
P1476
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
@en
P2093
David T Yang
Fotis Asimakopoulos
John M Denu
Kreg M Grindle
Peiman Hematti
Ryan A Denu
P2860
P304
P356
10.1074/JBC.M115.702076
P407
P577
2015-12-02T00:00:00Z